Loading...

APC/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
  • 30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
    C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Save
103115 25 µg ¥17,450
103116 100 µg ¥34,890
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Heindl S, et al. 2021. J Exp Med. 218:. PubMed
  2. Stefkovich M, et al. 2021. Mol Metab. 54:101357. PubMed
  3. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  4. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  5. De Vries LCS, et al. 2021. J Crohns Colitis. 15:617. PubMed
  6. Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed
  7. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  8. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  9. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  10. Ren D, et al. 2022. STAR Protoc. 3:101217. PubMed
  11. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  12. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  13. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  14. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  15. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  16. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  17. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  18. Naito H, et al. 2020. Nature Protocols. 15(3):1066-1081. PubMed
  19. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  20. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  21. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  22. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  23. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  24. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  25. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  26. Page N, et al. 2018. Immunity. 48:937. PubMed
  27. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  28. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  29. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  30. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  31. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  32. Urban SK, et al. 2020. Liver Int. 40:3103. PubMed
  33. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  34. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  35. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  36. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  37. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  38. Baram T, et al. 2021. Cells. 10:. PubMed
  39. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  40. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  41. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  42. Adrover JM, et al. 2022. JCI Insight. 7:. PubMed
  43. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  44. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  45. Kawashima N, et al. 2022. Nat Commun. 13:1624. PubMed
  46. Zhu S, et al. 2022. Front Pharmacol. 13:996635. PubMed
  47. Palacios LM, et al. 2022. Biology (Basel). 11:. PubMed
  48. Ebneter A, et al. 2017. Transl Vis Sci Technol. 10.1167/tvst.6.2.10. PubMed
  49. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  50. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  51. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  52. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  53. Pluchino N, et al. 2020. J Cell Mol Med. 24:2464. PubMed
  54. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  55. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  56. Evans H, et al. 2015. J Immunol. 195: 2973 - 2984. PubMed
  57. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  58. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  59. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  60. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  61. Biswas S, et al. 2021. Nature. 591:464. PubMed
  62. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  63. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  64. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  65. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  66. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  67. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  68. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  69. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  70. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  71. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  72. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  73. Armaka M, et al. 2022. Genome Med. 14:78. PubMed
  74. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  75. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  76. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  77. Wiley CD, et al. 2019. JCI Insight. 4:e130056. PubMed
  78. Krasteva G, et al. 2011. Proc Natl Acad Sci U S A. 108:9478. PubMed
  79. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  80. Shibata K, et al. 2014. J Immunol. 192:2210. PubMed
  81. Mantia-Smaldone G, et al. 2014. Gynecol Oncol. 133:584. PubMed
  82. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  83. AR P, et al. 2016. Circ Res. 118: 400-409. PubMed
  84. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  85. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  86. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  87. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  88. Schönfeld M, et al. 2021. Alcohol Clin Exp Res. 45:1980. PubMed
  89. Bhattacherjee A, et al. 2021. Mol Neurodegener. 16:19. PubMed
  90. Bagayoko S, et al. 2021. PLoS Pathog. 17:e1009927. PubMed
  91. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  92. Huang B, et al. 2020. Cell. 179(5):1160-1176.e24.. PubMed
  93. Ning F, et al. 2019. J Exp Med. 216:1396. PubMed
  94. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  95. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  96. Evans R, et al. 2019. Cell Rep. 27:1967. PubMed
  97. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  98. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  99. Marangoni F, et al. 2021. Cell. . PubMed
  100. Wang LT, et al. 2021. STAR Protocols. 2(1):100337. PubMed
  101. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  102. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  103. Cordeiro O, et al. 2016. PLoS One. 11: 0151848. PubMed
  104. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  105. Donlan AN, et al. 2020. Anaerobe. 66:102275. PubMed
  106. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  107. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  108. Commerford CD et al. 2018. Cell reports. . PubMed
  109. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  110. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  111. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  112. Weiner AI, et al. 2019. NPJ Regen Med. 4:17. PubMed
  113. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  114. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  115. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  116. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  117. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  118. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  119. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  120. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  121. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  122. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
  123. Gao H, et al. 2021. Cells. 10:. PubMed
  124. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  125. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  126. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  127. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  128. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  129. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  130. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  131. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  132. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  133. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  134. Zhang X, et al. 2020. Elife. 9:00. PubMed
  135. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  136. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  137. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  138. Ali M, et al. 2022. JCI Insight. 7:. PubMed
  139. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  140. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  141. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  142. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  143. Ayaub E,et al. 2017. Sci Rep.. 10.1038/s41598-017-13511-z. PubMed
  144. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  145. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  146. Veremeyko T, et al. 2012. J Vis Exp. 65: 4097. PubMed
  147. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  148. Oladiran O, et al. 2021. J Neuroinflammation. 77:18. PubMed
  149. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  150. Neuhöfer P, et al. 2021. Nature. 597:715. PubMed
  151. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  152. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  153. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  154. Selvaraj UM, et al. 2021. Brain Behav Immun. 95:502. PubMed
  155. Ying T, et al. 2021. Am J Physiol Endocrinol Metab. 320:E1148. PubMed
  156. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  157. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  158. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  159. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  160. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  161. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  162. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  163. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  164. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  165. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  166. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  167. Martina M, et al. 2014. J Vis Exp. 87: 51192. PubMed
  168. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  169. Yang Y, et al. 2022. Elife. 11:. PubMed
  170. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  171. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  172. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  173. Hoeksema M, et al. 2015. J Immunol. 194:3909. PubMed
  174. Dhanwani R, et al. 2020. Sci Adv. 6:eaba3688. PubMed
  175. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  176. Cardenas JJ, et al. 2020. Methods Enzymol. 415:631. PubMed
  177. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  178. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  179. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  180. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  181. Clement CC, et al. 2021. Nat Commun. 12:4447. PubMed
  182. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  183. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  184. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  185. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  186. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  187. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  188. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  189. Gierut J, et al. 2015. Stem Cell Res. 15: 165-171. PubMed
  190. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  191. Haka A, et al. 2012. PLoS One. 7:e44823. PubMed
  192. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  193. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  194. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  195. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  196. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  197. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  198. Veremeyko T, et al. 2019. J Neurosci Res. 97:162. PubMed
  199. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  200. Kim MY, et al. 2018. Cell. 173:1439. PubMed
  201. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  202. Michaelis KA, et al. 2019. Brain Behav Immun. 82:338. PubMed
  203. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  204. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  205. DiToro D, et al. 2020. Immunity. 650:52. PubMed
  206. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  207. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  208. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  209. Wang X, et al. 2022. Front Immunol. 13:864984. PubMed
  210. Galani IE, et al. 2022. STAR Protoc. 3:101151. PubMed
  211. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  212. Draper D, et al. 2012. J Immunol. 188:5327. PubMed
  213. Hohsfield LA, et al. 2020. J Neuroinflammation. 0.902083333. PubMed
  214. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  215. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  216. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  217. Selvaraj UM et al. 2018. Endocrinology. 159(11):3848-3859 . PubMed
  218. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  219. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  220. Ou YC, et al. 2020. ACS Nano. 1.035416667. PubMed
  221. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  222. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  223. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  224. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  225. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  226. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  227. Lu Z, et al. 2021. J Clin Invest. 131:. PubMed
  228. Luo M, et al. 2021. J Immunol. 207:1683. PubMed
  229. Wakabayashi T et al. 2018. Cell stem cell. 22(3):384-397 . PubMed
  230. Kaiser T, et al. 2019. Eneuro. 6. PubMed
  231. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  232. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  233. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  234. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  235. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  236. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  237. Pedicone C, et al. 2022. iScience. 25:104170. PubMed
  238. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  239. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  240. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  241. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  242. Milich LM, et al. 2021. J Exp Med. 218:. PubMed
  243. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  244. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  245. Starikova E, et al. 2021. Front Pharmacol. 12:667572. PubMed
  246. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  247. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  248. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  249. Jiang P, et al. 2018. Nat Med. 24:1550. PubMed
  250. Wang X, et al. 2018. Nat Commun. 9:551. PubMed
  251. Klein S, et al. 2016. J Cell Sci. 129: 2573 - 2585. PubMed
  252. Morein D, et al. 2021. Cells. 10: . PubMed
  253. Yan C, et al. 2022. NPJ Precis Oncol. 6:6. PubMed
  254. Phansalkar R, et al. 2021. Elife. 10:. PubMed
  255. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  256. Armaka M, et al. 2018. Nat Commun. 9:618. PubMed
  257. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  258. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  259. Martin A, et al. 2018. Oncotarget. 9:28364. PubMed
  260. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  261. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  262. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  263. Gago-Lopez N, et al. 2019. EMBO Mol Med. 11:e10697. PubMed
  264. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  265. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  266. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  267. Ling Y, et al. 2016. Pharmacol Res. S1043-6618(16)31329-9. PubMed
  268. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  269. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  270. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  271. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  272. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  273. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  274. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  275. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  276. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  277. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  278. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  279. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  280. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  281. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  282. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  283. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  284. Liu SS, et al. 2021. Immunity. :. PubMed
  285. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  286. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
  287. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  288. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  289. Seeling M, et al. 2013. Proc Natl Acad Sci U S A. 110:10729. PubMed
  290. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  291. De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed
  292. Sibler E, et al. 2021. Cells. 10:. PubMed
  293. Oladiran O, et al. 2021. Front Immunol. 12:720733. PubMed
  294. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  295. Sebastian A, et al. 2021. Cells. 10:. PubMed
  296. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  297. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  298. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  299. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  300. Forte E, et al. 2020. Cell Rep. 30:3149. PubMed
  301. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  302. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  303. Lux A, et al. 2014. Cell Rep. 10:236. PubMed
  304. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  305. Fox B, et al. 2016. PLoS One. 12: 1006189. PubMed
  306. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  307. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  308. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  309. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  310. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  311. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
  312. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  313. Sun D, et al. 2020. PLoS Pathog. 16:e1008361. PubMed
  314. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  315. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  316. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  317. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  318. Parent AV, et al. 2021. Cell Reports. 36(7):109538. PubMed
  319. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  320. Ma Y, et al. 2021. Developmental Cell. 56(4):478-493.e11. PubMed
  321. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  322. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  323. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
RRID
AB_312980 (BioLegend Cat. No. 103115)
AB_312981 (BioLegend Cat. No. 103116)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 01/30/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account